Association of blood levels of urokinase plasminogen activator and its soluble receptor with prostate cancer presence, invasion, progression, and metastasis

被引：0
|
作者：
Shariat, S.
McConnell, J.
Park, S.
Wheeler, T.
Slawin, K.
Roehrborn, C.
机构：
[1] Univ Texas SW, Dallas, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60903-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [41] The Urokinase Receptor Promotes Cancer Metastasis Independently of Urokinase-Type Plasminogen Activator in Mice
    Jo, Minji
    Takimoto, Shinako
    Montel, Valerie
    Gonias, Steven L.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (01): : 190 - 200
  • [42] SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN ANKYLOSING SPONDYLITIS: THE IMPACT OF INFLIXIMAB THERAPY
    Biro, E.
    Szalay, B.
    Balog, A.
    Vasarhelyi, B.
    Beko, G.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S203 - S203
  • [43] Levels of Soluble Urokinase Plasminogen Activator Receptor in Pediatric Lower Respiratory Tract Infections
    Citlenbik, Hale
    Ulusoy, Emel
    Er, Anil
    Caglar, Aykut
    Akgul, Fatma
    Kume, Tuncay
    Yilmaz, Durgul
    Duman, Murat
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2019, 32 (03) : 121 - 127
  • [44] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Bocskai, Marta
    Deak, Magdolna
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    BIOMARKERS, 2012, 17 (08) : 758 - 763
  • [45] Comment on: Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients With Heart Failure
    Qadeer, Ahsan
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (12)
  • [46] Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis
    Yilmaz, Huriye Erbak
    Aksun, Saliha
    Gunay, Sueleyman
    Elmali, Ferhan
    Cekic, Cem
    ARAB JOURNAL OF GASTROENTEROLOGY, 2023, 24 (03) : 175 - 179
  • [47] Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes
    Tahhan, Ayman Samman
    Hayek, Salim S.
    Sandesara, Pratik
    Hajjari, Jamal
    Hammadah, Muhammad
    O'Neal, Wesley T.
    Kelli, Heval M.
    Alkhoder, Ayman
    Ghasemzadeh, Nima
    Ko, Yi-An
    Aida, Hiroshi
    Gafeer, Mohamad Mazen
    Abdelhadi, Naser
    Mohammed, Kareem Hosny
    Patel, Keyur
    Arya, Shipra
    Reiser, Jochen
    Vaccarino, Viola
    Sperling, Laurence
    Quyyumi, Arshed
    ATHEROSCLEROSIS, 2017, 264 : 108 - 114
  • [48] Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer
    Konecny, G
    Untch, M
    Pihan, A
    Kimmig, R
    Gropp, M
    Stieber, P
    Hepp, H
    Slamon, D
    Pegram, M
    CLINICAL CANCER RESEARCH, 2001, 7 (06) : 1743 - 1749
  • [49] UROKINASE PLASMINOGEN-ACTIVATOR IS NECESSARY BUT NOT SUFFICIENT FOR PROSTATE-CANCER CELL INVASION
    JARRARD, DF
    HANSEN, NM
    PATAI, B
    RUKSTALIS, DB
    INVASION & METASTASIS, 1995, 15 (1-2): : 34 - 45
  • [50] The levels of soluble urokinase plasminogen activator receptor (suPAR) in saliva are influenced by acute stress
    Fernandez-Botran, Rafael
    Szabo, Yvette Z.
    Lyle, Keith B.
    Newton, Tamara L.
    BIOLOGICAL PSYCHOLOGY, 2021, 165
12345